 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$1.16 |
$1.17 |
$1.09 |
$1.13 |
427.20K | | 04/19/2024 |
$1.12 |
$1.17 |
$1.10 |
$1.15 |
449.80K | | 04/22/2024 |
$1.15 |
$1.18 |
$1.12 |
$1.18 |
225.10K | | 04/23/2024 |
$1.16 |
$1.24 |
$1.16 |
$1.20 |
272.10K | | 04/24/2024 |
$1.19 |
$1.23 |
$1.17 |
$1.21 |
228.30K |
|
|
| Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products. Co.'s clinical development program for pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease. In addition, Co. is developing uricase, or PRX-115, for the treatment of refractory gout. | |
|
Protalix BioTherapeutics (PLX) has the following price history information. Looking back at PLX historical stock prices for the last five trading days, on April 18, 2024, PLX opened at $1.16, traded as high as $1.17 and as low as $1.09, and closed at $1.13. Trading volume was a total of 427.20K shares. On April 19, 2024, PLX opened at $1.12, traded as high as $1.17 and as low as $1.10, and closed at $1.15. Trading volume was a total of 449.80K shares. On April 22, 2024, PLX opened at $1.15, traded as high as $1.18 and as low as $1.12, and closed at $1.18. Trading volume was a total of 225.10K shares. On April 23, 2024, PLX opened at $1.16, traded as high as $1.24 and as low as $1.16, and closed at $1.20. Trading volume was a total of 272.10K shares. On April 24, 2024, PLX opened at $1.19, traded as high as $1.23 and as low as $1.17, and closed at $1.21. Trading volume was a total of 228.30K shares.
PLX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protalix BioTherapeutics shares, starting with a $10,000 purchase of PLX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$40.90 |
|
| End price/share: |
$1.21 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-97.04% |
|
| Average Annual Total Return: |
-29.68% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$295.94 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $1.13 | | 04/19/2024 | $1.15 | | 04/22/2024 | $1.18 | | 04/23/2024 | $1.20 | | 04/24/2024 | $1.21 |
|
|
Free PLX Email Alerts:
